SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Shasun receives USFDA approval for Dutasteride Softgel Capsule

23 Nov 2015 Evaluate

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Dutasteride Capsules, 0.5 mg. The product is ready for Day 1 launch. The product will be manufactured at the company’s Oral dosage facility at Bangalore and marketed by Strides Shasun in the US Market.

The US market for Dutasteride Capsules is approximately $470 million. The product has gone off patent on November 20, 2015 and Strides Shasun is amongst the first wave of generic players to receive this approval.

Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Pharmaceutical Services & Active Ingredients.


Strides Pharma Scien Share Price

1005.05 4.35 (0.43%)
20-Apr-2026 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.70
Dr. Reddys Lab 1236.30
Cipla 1234.50
Zydus Lifesciences 938.80
Lupin 2323.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×